Krabbe disease is a rare, inherited neurological disorder that affects the nervous system, leading to the progressive destruction of myelin — the protective covering of nerve cells. This results in impaired movement, muscle stiffness, developmental delays, and sensory difficulties. Early diagnosis and comprehensive care are essential to slow progression, manage symptoms, and improve quality of life.
Krabbe disease is caused by mutations in the GALC gene, which leads to deficiency of the enzyme galactocerebrosidase. This disrupts myelin production and damages the nervous system.
Parents who are carriers of the GALC gene mutation have a higher risk of passing the disease to their children.
Infantile Krabbe disease, the most severe form, typically appears in the first few months of life. Late-onset forms can appear in childhood, adolescence, or adulthood.
Diagnosis begins with a careful neurological and developmental evaluation, including assessment of motor skills, muscle tone, reflexes, and sensory function. Blood tests are performed to measure galactocerebrosidase enzyme activity, and genetic testing confirms mutations in the GALC gene. Imaging studies such as MRI may be used to detect abnormalities in the brain and spinal cord. This thorough assessment ensures an accurate diagnosis and guides a personalized care plan.
A Personalised Multi-Approach Plan — combining medications, therapy, lifestyle support, and advanced interventions.
Each plan is customized according to the type and severity of Krabbe disease, age of onset, and individual patient needs. Treatments are adjusted continuously as the patient progresses to ensure optimal results.
Medication Therapy
Medications are prescribed to manage muscle stiffness, seizures, and neuropathic pain. These help improve comfort, reduce complications, and support daily functioning.
Advanced Interventions
In selected cases, hematopoietic stem cell transplantation (HSCT) or gene therapy may be recommended to slow disease progression. These interventions are most effective when administered early and are personalized according to patient condition.
Lifestyle & Support Programs
Caregiver education, nutritional support, structured routines, and environmental adaptations are integrated to optimize developmental outcomes and daily living.
Together, these therapies work on the nervous system, muscles, and daily function, helping reduce symptoms, improve mobility and coordination, and support developmental and functional outcomes.
| What Makes Our Practice Different | |||||
|---|---|---|---|---|---|
|
Personalised Protocols
Every plan tailored to the individual
|
Advanced Technology
Cutting-edge non-invasive therapeutic science
|
Mechanism-Based Care
We treat biology, not just symptoms
|
23+ Years Experience
Decades of specialist clinical wisdom
|
Whole Person Approach
Mind, body & lifestyle integrated
|
Objective Outcomes
Measurable results — not just relief
|
What is Krabbe Disease?
Krabbe disease is a rare, inherited neurological disorder that affects the nervous system. It is caused by the deficiency of a specific enzyme called galactocerebrosidase (GALC), which is essential for breaking down certain fatty substances in the body. Without this enzyme, harmful substances build up in the cells of the nervous system, leading to the progressive damage of the brain and spinal cord.
Krabbe disease is typically diagnosed in infancy, and it is most common in children under the age of two. The disease progresses rapidly and can result in severe neurological damage, but early intervention and treatment can help manage symptoms and improve quality of life.
Symptoms of Krabbe Disease
The symptoms of Krabbe disease vary depending on the age of onset and the severity of the condition. Common signs of Krabbe disease in infants include:
As the disease progresses, symptoms worsen, leading to developmental regression, loss of motor skills, and in severe cases, death in early childhood.
What Causes Krabbe Disease?
Krabbe disease is inherited in an autosomal recessive manner. This means that a child must inherit two copies of the defective gene (one from each parent) to develop the disease. Parents who are carriers of the gene for Krabbe disease do not show symptoms themselves but can pass the gene to their children.
The disease is caused by mutations in the GALC gene, which leads to a deficiency of the galactocerebrosidase enzyme. Without this enzyme, a fatty substance called galactocerebroside builds up in the cells of the nervous system, causing progressive damage to the brain, spinal cord, and peripheral nerves.
Treatment Options for Krabbe Disease
Currently, there is no cure for Krabbe disease, and treatment mainly focuses on managing symptoms and improving quality of life. Treatment options include:
When to Consult a Neurophysician for Krabbe Disease
If your child shows developmental delays, unusual irritability, muscle weakness, or feeding difficulties, it is important to consult a neurophysician or pediatric neurologist. Early diagnosis and intervention are crucial for managing symptoms and improving quality of life.